Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aveanna Healthcare Holdings (AVAH) EBITDA Margin: 2020-2025

Historic EBITDA Margin for Aveanna Healthcare Holdings (AVAH) over the last 6 years, with Q3 2025 value amounting to 8.62%.

  • Aveanna Healthcare Holdings' EBITDA Margin rose 19300.0% to 8.62% in Q3 2025 from the same period last year, while for Sep 2025 it was 10.09%, marking a year-over-year increase of 38800.0%. This contributed to the annual value of 7.38% for FY2024, which is 63300.0% up from last year.
  • As of Q3 2025, Aveanna Healthcare Holdings' EBITDA Margin stood at 8.62%, which was up 19300.0% from 13.58% recorded in Q2 2025.
  • Aveanna Healthcare Holdings' EBITDA Margin's 5-year high stood at 13.58% during Q2 2025, with a 5-year trough of 103.03% in Q3 2022.
  • Moreover, its 5-year median value for EBITDA Margin was 6.12% (2023), whereas its average is 3.56%.
  • As far as peak fluctuations go, Aveanna Healthcare Holdings' EBITDA Margin tumbled by -1099800bps in 2022, and later surged by 1109800bps in 2023.
  • Aveanna Healthcare Holdings' EBITDA Margin (Quarter) stood at 4.46% in 2021, then plummeted by -1116bps to 45.32% in 2022, then skyrocketed by 113bps to 6.12% in 2023, then soared by 44bps to 8.8% in 2024, then decreased by -2bps to 8.62% in 2025.
  • Its EBITDA Margin was 8.62% in Q3 2025, compared to 13.58% in Q2 2025 and 9.26% in Q1 2025.